Neovasc is a Canada-based medical device company that develops, manufactures, and markets minimally invasive devices for the treatment of refractory angina.
Business Model:
Revenue: $3M
Employees: 51-200
Address: 13700 Mayfield Place
City: Richmond
State: british columbia
Zip: V6V 2E4
Country: CA
Neovasc is a Canada-based medical device company that develops, manufactures, and markets minimally invasive devices for the treatment of refractory angina.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/12/2008
Ticker Symbol:
NVCN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2020 | Post-IPO Equity | $12.6M | 6/2020 | Post-IPO Debt | $5M | 2/2019 | Post-IPO Equity | $5M | 11/2017 | Post-IPO Equity | $65.3M | 5/2019 | Post-IPO Debt | $12M | 2/2021 | Post-IPO Equity | $72M | 12/2020 | Post-IPO Equity | $6.1M | 4/2018 | Post-IPO Equity | $7.1M | 12/2016 | Post-IPO Equity | 1 | $75M |
Boston Scientific Boston Scientific |
1/2015 | Post-IPO Equity | $74.9M | 5/2009 | Post-IPO Equity | $1.5M | 3/2014 | Post-IPO Equity | $22.5M | 6/2020 | Post-IPO Equity | $11.5M | 1/2006 | Seed Round | 1 | $3.2M |
Peregrine Ventures Peregrine Ventures |
1/2020 | Post-IPO Equity | $11.5M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|